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ublished by Elsevier Inc.Angiographic Patterns of Restenosis After Paclitaxel-Eluting Stent Implantation
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do the Editor: Polymer-based paclitaxel-eluting stents (PES)
Taxus, Boston Scientific, Natick, Massachusetts) have been
hown to reduce neointimal hyperplasia and risk of restenosis (1,2).
perators are now using drug-eluting stents for a wide variety of
linical and anatomical situations, many of which have not been
nvestigated in randomized studies.
The clinical and morphologic features of restenosis after PES
mplantation have not been adequately evaluated (1,2). The pur-
ose of this study was to describe the angiographic patterns of
estenosis after PES implantation in “real-world” patients. This
nowledge may help in finding the solution to this important
roblem.
We identified 977 consecutive patients who underwent PES
mplantation (977 procedures, 1,688 lesions, 2,023 stents) in three
nstitutions between April 2002 and March 2004. Patients that
ad in-stent restenosis (ISR) lesions treated, prior brachytherapy at
he target vessel, or acute myocardial infarction 48 h before the
ndex procedure were excluded. All patients were pretreated with
iclopidine or clopidogrel and aspirin; a loading dose of 300 mg
lopidogrel was given to patients not previously taking the agent.
spirin was continued indefinitely and clopidogrel or ticlopidine
or at least six months after PES implantation. Glycoprotein
Ib/IIIa inhibitors were administered at the operators’ discretion.
During follow-up, coronary angiograms were obtained as clin-
cally driven (30 days after procedure, indicated by symptoms or
ositive ischemic tests). In addition, follow-up angiograms were
btained at 6  1 month in patients treated with PES implanta-
ion for bifurcations, left main, chronic total occlusions, small
essels, and long stented length (36 mm). Cineangiograms were
nalyzed using a validated edge detection system (CMS, version
.2, MEDIS, Leiden, the Netherlands). Standard qualitative and
uantitative analyses and definitions were used (3). Angiographic
uccess was defined as a minimum stenosis diameter 20% after
tenting. For the current study, ISR cases were categorized
ccording to Mehran classification (4).
Baseline demographics, lesion, and procedural characteristics
re shown in Table 1. Twenty-six percent of the patient population
ad diabetes and 78% of the lesions were complex (B2 or C type).
n addition, 19% of the lesions were bifurcational and 7.9% were
otal occlusions. All patients had successful PES implantation, and
here was no angiographic evidence of any residual dissection after
ES implantation. The mean stent per lesion ratio was 1.23, and
lycoprotein IIb/IIIa inhibitors were used in 40% of the patients.
To date, all 977 patients have completed 6 months from the
ndex procedure. At a mean follow-up of 10.5  3.6 months, the
ates of target lesion revascularization, target vessel revasculariza-
ion (TVR) and major adverse cardiac events (death, myocardial
nfarction, or TVR) were 7.2%, 10.3%, and 11.4%, respectively. A
ollow-up coronary angiogram was obtained in 576 patients (59%)
747 lesions), and in 201 patients (35%) the angiogram was
linically driven.Among these, ISR was identified in 81 patients
nd 98 lesions. The mean baseline reference vessel diameter was
.60 mm. Mean baseline lesion length was 14.10 10.12 mm, and Iestenotic lesion length was 9.96  6.07 mm (range 2.18 to 26.18
m), which corresponds to 29% reduction.
Restenosis was found in the body and the edges in 71 lesions
72%), in the edges only in 16 lesions (16%), and in the body of the
tent only in 11 lesions (11%). A schematic representation of the
atterns of ISR is shown in Figure 1. The pattern of ISR in 49
esions (50%) was focal (10 mm in length) or multifocal (12% of
he focal lesions). In the remaining 49 lesions (50%), the pattern of
able 1. Baseline Demographics, Lesion and Procedural
haracteristics, and Pre- and Post-Intervention Angiographic
nalysis
PES
atient characteristics
Patients (n) 977
Unstable angina (%) 27
Diabetes (%) 26
Previous myocardial infarction (%) 44
Previous percutaneous coronary intervention (%) 41
Previous bypass surgery (%) 23
Multivessel disease (%) 82
Left ventricular ejection fraction (%) 53  10
esion characteristics
Lesions (n) 1,688
Vessels treated
Left main unprotected (%) 2.6
Left anterior descending artery (%) 43
Saphenous vein graft (%) 2.3
Ostial location (%) 12
Bifurcation (%) 19
Calcium (%) 16
Preintervention TIMI flow grade 3 (%) 84
Thrombus (%) 2.4
Total occlusion (%) 7.9
rocedural characteristics
Procedures (n) 977
Maximum balloon diameter (mm) 3.04  0.51
Maximum balloon inflation (atm) 15.9  3.5
Stent length per lesion (mm) 27.45  12.56
Stents per lesion 1.23  0.55
Glycoprotein IIb/IIIa inhibitors (%) 40
uantitative coronary angiography
Lesions (n) 1,688
Preintervention
RVD (mm) 2.60  0.70
MLD (mm) 0.96  0.25
DS (%) 66  18
Lesion length (mm) 14.10  10.12
Post-intervention
MLD (mm) 2.73  0.62
DS (%) 13  11
alues are presented as numbers (relative percentages) or mean  SD.
DS  diameter stenosis; MLD  minimal lumen diameter; PES  paclitaxel-
luting stent; RVD  reference vessel diameter; TIMI  Thrombolysis In Myocar-
ial Infarction.SR was non-focal: diffuse ISR (10 mm in length) in 28 lesions
(
o
b
i
s
r
e
P
fi
r
t
a
p
f
l
T
d
d
l
n
S
o
b
e
“
r
c
p
c
a
o
p
f
r
a
a
p
(
p
n
o
i
d
s
I
T
L
G
G
F
A
M
M
I
N
J
U
E
*
*
4
2
E
R
1
2
3
4
5
6
7
L
R
S
e
R
s
c
s
F
(
806 Correspondence JACC Vol. 45, No. 5, 2005
March 1, 2005:805–1129%) (25 diffuse proliferative and 3 diffuse intrastent) and total
cclusions in 21 lesions (21%).
Traditionally, the presence of a focal ISR represents a rather
enign type of ISR (5). Mehran et al. (4) showed that diffuse
ntrastent, proliferative, and totally occluded ISR make up a
pectrum of increasing disease severity (exaggerated neointimal
esponse). In our study, in contrast to data regarding sirolimus-
luting stents in unselected lesions (6,7), the pattern of ISR after
ES implantation was non-focal in 50% of the cases. Whether this
nding represents a more exaggerated neointimal response to PES
emains to be seen in the ongoing and the upcoming randomized
rials between the two types of drug-eluting stents currently
vailable in the market. It is worth noting that in TAXUS IV the
attern of restenosis in 16 lesions with ISR was predominantly
ocal (62%), but still a considerable percentage (38%) of ISR
esions were non-focal (1). Our study population, compared with
AXUS IV patients, consisted of patients with similar rates of
iabetes (26% vs. 24%). However, the mean reference vessel
iameter was smaller (2.60 mm vs. 2.75 mm) and the mean lesion
ength was longer (14.10 mm vs. 13.10 mm). In addition, a greater
umber of stents per lesion were used in our study (1.23 vs. 1.08).
imilar to previous reports with sirolimus-eluting stents, ISR
ccurred more frequently in the proximal than in the distal stent
order (6,7). This finding, which has been attributed to more
ffective drug effect in the outflow stent border and a possible
wash-out” of the drug, remains to be clarified (7).
The current study presents several limitations. First, this was a
etrospective analysis with the inherent caveat of the abscence of a
ontrol group. Offsetting this limitation, the data were collected
rospectively by independent monitors and entered into a dedi-
ated database, and an independent core laboratory interpreted all
ngiographic studies. Angiographic follow-up was available in 59%
f the patients and in 35% of patients was clinically driven, thereby
recluding a homogeneous evaluation of the total restenosis rate
or the global treated population. However, the patterns of
estenosis were similar between patients that had clinically driven
ngiography and patients that had systematic elective control
ngiography. More specifically, out of the 36 ISR lesions in the 28
atients that underwent clinically driven coronary angiogram, 18
50%) were non-focal; of the 63 lesions in the remaining 53
atients that underwent elective control angiogram, 31 (45%) were
on-focal (p  0.9).
In conclusion, restenosis after PES implantation appears in 50%
igure 1. Schematic representation of the patterns of in-stent restenosis
ISR) after paclitaxel-eluting stent implantation.f patients with a non-focal pattern and in the majority of the cases bnvolves the stent edges and more frequently the proximal than the
istal border. Diffuse proliferative ISR and ISR with total occlu-
ions are the predominant patterns when non-focal ISR occurs.
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etters to the Editor
escue Angioplasty—The MERLIN Trial
ome of the issues raised by Drs. Grines and O’Neill in their
ditorial in JACC (1) accompanying the Middlesbrough Early
evascularization to Limit Infarction (MERLIN) trial report (2)
hould be addressed.
Before the trial initiation, we estimated 18% mortality in the
onservative group and 6% in the rescue group, as described in the
tatistical methods section. This may have been optimistic, but was
ased upon a careful literature search. Power calculations cannot be
